[Place of PARP inhibitors in the treatment of endometrial and cervical cancers].
Le Gac M, Koual M, Delanoy N, Perkins G, Nguyen-Xuan HT, Blons H, Le Frère-Belda MA, Laurent-Puig P, Bentivegna E, Durdux C, Azaïs H, Bats AS.
Le Gac M, et al.
Bull Cancer. 2022 Jan;109(1):65-75. doi: 10.1016/j.bulcan.2021.09.011. Epub 2021 Nov 17.
Bull Cancer. 2022.
PMID: 34801228
Review.
French.